Blood consumption in the Role 2 setting: A Department of Defense Trauma Registry analysis.

Autor: McWhirter KK; 2nd Stryker Brigade Combat Team, 4th Infantry Division, Fort Carson, Colorado, USA.; Shenandoah University, Winchester, Virginia, USA., April MD; 14th Field Hospital, Fort Stewart, Georgia, USA.; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Fisher AD; Department of Surgery, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.; Texas National Guard, Austin, Texas, USA., Wright FL; Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado, USA., Rizzo JA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Brooke Army Medical Center, JBSA Fort Sam Houston, Texas, USA., Corley JB; Medical Capability Development Integration Directorate, JBSA Fort Sam Houston, Texas, USA., Getz TM; Center for Combat and Battlefield (COMBAT) Research, Aurora, Colorado, USA., Schauer SG; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Center for Combat and Battlefield (COMBAT) Research, Aurora, Colorado, USA.; Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jazyk: angličtina
Zdroj: Transfusion [Transfusion] 2024 May; Vol. 64 Suppl 2, pp. S42-S49. Date of Electronic Publication: 2024 Feb 15.
DOI: 10.1111/trf.17741
Abstrakt: Background: The Role 2 setting represents the most far-forward military treatment facility with limited surgical and holding capabilities. There are limited data to guide recommendations on blood product utilization at the Role 2. We describe the consumption of blood products in this setting.
Study Design and Methods: We analyzed data from 2007 to 2023 from the Department of Defense Trauma Registry (DODTR) that received care at a Role 2. We used descriptive and inferential statistics to characterize the volumes of blood products consumed in this setting. We also performed a secondary analysis of US military, Coalition, and US contractor personnel.
Results: Within our initial cohort analysis of 15,581 encounters, 17% (2636) received at least one unit of PRBCs or whole blood, of which 11% received a submassive transfusion, 4% received a massive transfusion, and 1% received a supermassive transfusion. There were 6402 encounters that met inclusion for our secondary analysis. With this group, 5% received a submassive transfusion, 2% received a massive transfusion, and 1% received a supermassive transfusion.
Conclusions: We described volumes of blood products consumed at the Role 2 during recent conflicts. The maximum number of units consumed among survivors exceeds currently recommended available blood supply. Our findings suggest that rapid resupply and cold-stored chain demands may be higher than anticipated in future conflicts.
(© 2024 AABB. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.)
Databáze: MEDLINE
Externí odkaz: